Original Research
Accepted on 24 Oct 2025
Preclinical Evaluation of uPAR-ICG-FVIOs for Dual-Mode Imaging and Magnetic Hyperthermia Therapy in Pancreatic Cancer
in Translational Pharmacology
Original Research
Accepted on 24 Oct 2025
in Translational Pharmacology
Retraction
Accepted on 24 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 24 Oct 2025
in Renal Pharmacology
Original Research
Accepted on 24 Oct 2025
in Ethnopharmacology
Original Research
Accepted on 24 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 24 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 24 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 24 Oct 2025
in Experimental Pharmacology and Drug Discovery
Review
Accepted on 24 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 24 Oct 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 24 Oct 2025
in Translational Pharmacology
Review
Accepted on 24 Oct 2025
in Translational Pharmacology
Original Research
Accepted on 24 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 24 Oct 2025
in Ethnopharmacology
Original Research
Accepted on 24 Oct 2025
in Pharmacoepidemiology
Original Research
Accepted on 24 Oct 2025
in Neuropharmacology